Clinical trial
Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts
NCT01668706 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts
- Lead sponsor
- National Health Research Institutes, Taiwan
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- December 31, 2013
- Enrollment
- 340 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.